Associate Director of Tax, Ataia
Digital therapeutic tools
Be an early applicant
Digital therapeutic tools
1-20 employees
Be an early applicant
1-20 employees
Company mission
To empower patients with the freedom of SPEAX.
Jump to section
Company mission
To empower patients with the freedom of SPEAX.
Our take
Non-invasive ventilation (NIV) can be a life-saving intervention for patients, but the mask means verbal communication is tough. This has been proven to substantially hike up patient anxiety and, subsequently, early treatment-discontinuation rates. With good reason, too: being able to communicate with your family or physician, especially in case of further medical incident, is vital - and the current standard practice of written notes or mime just doesn’t pass muster.
Ataia Medical has devised a long overdue solution. Its SPEAX product consists of a stick-on microphone that attaches to the patient’s NIV mask, which is then connected to a speaker system with adjustable volume control so that speech can be crisply and clearly understood.
It’s a neat solution, but it’s hard to tell how much success Ataia has had shipping it out to healthcare providers and customers. The company may need to pick up the pace of distribution: ReddyPort has developed a similar microphone communications product for precisely this same application, and whilst they seem to be similarly modest in spread, this could scupper Ataia’s lead.
Steph
Company Specialist at Welcome to the Jungle
Funding (last 2 of 7 rounds)
Mar 2021
$157m
SERIES D
Nov 2020
$125m
SERIES C
Total funding: $385.6m
This company has top investors
Leadership
Tyler Register
(CEO)Graduated in Biomedical Engineering from Georgia Institute of Technology, having completed a number of placements at Mohawk Industries, Working Power Solutions, and Siemens.
Amy Foertsch
(COO)Following her degree in Biomedical Engineering at Georgia Institute of Technology, she spent time as an Associate Quality Engineer at Alcon.